Kenvue Inc (KVUE) has declared a dividend of $0.21 per share, payable to shareholders of record. The ex-dividend date is set for November 11, 2025, meaning investors must own shares before this date to qualify for the payment. Eligible shareholders will receive the dividend on November 25, 2025.
With a dividend yield of 4.92%, Kenvue continues its pattern of regular quarterly payments, which provide income to shareholders. The company's market capitalization stands at $32.3 billion, with a price-to-earnings ratio of 22.81 and earnings per share of 0.74.
Kenvue, a consumer health company based in Summit, New Jersey, manufactures and sells a range of healthcare products, including well-known brands such as Tylenol, Neutrogena, and Listerine. The company employs approximately 22,000 full-time staff and operates through three segments: Self Care, Skin Health and Beauty, and Essential Health.
The upcoming earnings report is scheduled for May 5, 2026, with estimated earnings per share of $0.26 and projected revenue of $3.9 billion. This update provides insight into Kenvue's cash flow generation and capital allocation strategy, which may appeal to income-focused investors.